ATE193442T1 - 3,4-diarylchromane zur behandlung von dermatitis - Google Patents

3,4-diarylchromane zur behandlung von dermatitis

Info

Publication number
ATE193442T1
ATE193442T1 AT94911467T AT94911467T ATE193442T1 AT E193442 T1 ATE193442 T1 AT E193442T1 AT 94911467 T AT94911467 T AT 94911467T AT 94911467 T AT94911467 T AT 94911467T AT E193442 T1 ATE193442 T1 AT E193442T1
Authority
AT
Austria
Prior art keywords
dermatitis
treatment
chromanes
diaryl
medicaments
Prior art date
Application number
AT94911467T
Other languages
English (en)
Inventor
James R Piggott
Original Assignee
Zymogenetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zymogenetics Inc filed Critical Zymogenetics Inc
Application granted granted Critical
Publication of ATE193442T1 publication Critical patent/ATE193442T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
AT94911467T 1993-03-11 1994-03-07 3,4-diarylchromane zur behandlung von dermatitis ATE193442T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/029,739 US5451603A (en) 1993-03-11 1993-03-11 3,4-diarylchromans for treatment of dermatitis
PCT/US1994/002387 WO1994020099A1 (en) 1993-03-11 1994-03-07 3,4-diarylchromans for treatment of dermatitis

Publications (1)

Publication Number Publication Date
ATE193442T1 true ATE193442T1 (de) 2000-06-15

Family

ID=21850620

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94911467T ATE193442T1 (de) 1993-03-11 1994-03-07 3,4-diarylchromane zur behandlung von dermatitis

Country Status (11)

Country Link
US (2) US5451603A (de)
EP (1) EP0688215B1 (de)
JP (1) JPH08506347A (de)
AT (1) ATE193442T1 (de)
CA (1) CA2158036C (de)
DE (1) DE69424777T2 (de)
DK (1) DK0688215T3 (de)
ES (1) ES2147788T3 (de)
GR (1) GR3034186T3 (de)
PT (1) PT688215E (de)
WO (1) WO1994020099A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6515009B1 (en) 1991-09-27 2003-02-04 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US5811447A (en) 1993-01-28 1998-09-22 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US6491938B2 (en) 1993-05-13 2002-12-10 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US5416098A (en) * 1993-12-30 1995-05-16 Zymogenetics, Inc. Method for treating dermatitis and related conditions
AU4328896A (en) * 1995-01-20 1996-08-07 Novo Nordisk A/S Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of cerebral degenerative disorders
US20030083733A1 (en) * 1997-10-10 2003-05-01 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US6099562A (en) * 1996-06-13 2000-08-08 Schneider (Usa) Inc. Drug coating with topcoat
US20020091433A1 (en) * 1995-04-19 2002-07-11 Ni Ding Drug release coated stent
US5837313A (en) * 1995-04-19 1998-11-17 Schneider (Usa) Inc Drug release stent coating process
US5624902A (en) * 1995-06-07 1997-04-29 Torrey Pines Institute For Molecular Studies Peptide inhibitors of calmodulin
US5958967A (en) * 1996-10-28 1999-09-28 Novo Nordisk A/S Cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
AU6959898A (en) * 1997-04-11 1998-11-11 David J. Grainger Compounds and therapies for the prevention of vascular and non-vascular pathol ogies
EP1028724A1 (de) * 1997-11-10 2000-08-23 Novo Nordisk A/S Transdermale verabreichung von 3,4-diarylchromane
US6613083B2 (en) * 2001-05-02 2003-09-02 Eckhard Alt Stent device and method
US7601855B2 (en) 2004-09-21 2009-10-13 Novogen Research Pty Ltd Substituted chroman derivatives, medicaments and use in therapy
US8080675B2 (en) 2004-09-21 2011-12-20 Marshall Edwards, Inc. Chroman derivatives, medicaments and use in therapy
EP2635121B1 (de) 2010-11-01 2020-01-08 MEI Pharma, Inc. Isoflavonoidverbindungen und verfahren zur behandlung von krebs
US9701655B2 (en) 2014-02-07 2017-07-11 Novogen Limited Functionalised benzopyran compounds and use thereof
HUE054998T2 (hu) 2015-02-02 2021-10-28 Mei Pharma Inc Kombinációs terápiák emlõrák kezelésében való alkalmazásra

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3340276A (en) * 1964-04-01 1967-09-05 Ciba Geigy Corp 3, 4-diphenyl-chromans
US3822287A (en) * 1969-04-17 1974-07-02 Rexall Drug Chemical Process for preparation of substituted 3,4-(diphenyl)chromans
GB1475503A (en) * 1973-12-19 1977-06-01 Fisons Ltd Topical compositions
US4447622A (en) * 1981-09-22 1984-05-08 Council Of Scientific And Industrial Research Rafi Marg Preparation of l- and d-isomers of dl-3,4-trans-2,2-disubstituted-3,4-diarylchromans and derivatives thereof
GB8604528D0 (en) * 1986-02-24 1986-04-03 Ici Plc Therapeutic agents
US4742066A (en) * 1986-03-17 1988-05-03 Charles Of The Ritz Group Ltd. Skin treatment composition and method
US5015661A (en) * 1988-08-09 1991-05-14 Hoffmann-La Roche Inc. Chromanes and their pharmaceutical compositions and methods
WO1990012010A1 (en) * 1989-04-07 1990-10-18 Pfizer Inc. Substituted chromans in the treatment of asthma, arthritis and related diseases
US5248777A (en) * 1989-09-19 1993-09-28 Allergan, Inc. Process and intermediates for preparing compounds having a disubstituted acetylene moiety and retinoic acid-like biological activity
US5302606A (en) * 1990-04-16 1994-04-12 Rhone-Poulenc Rorer Pharmaceuticals Inc. Styryl-substituted pyridyl compounds which inhibit EGF receptor tyrosine kinase
EP0553156A4 (en) * 1990-10-09 1993-11-18 Allergan, Inc. Chromans and thiochromans with retinoid-like activity
SG64322A1 (en) * 1991-05-10 1999-04-27 Rhone Poulenc Rorer Int Bis mono and bicyclic aryl and heteroaryl compounds which inhibit egf and/or pdgf receptor tyrosine kinase
WO1993020058A1 (en) * 1992-04-06 1993-10-14 Merrell Dow Pharmaceuticals Inc. Novel cardioprotective agents
EP0635011B1 (de) * 1992-04-07 1996-12-18 Merrell Pharmaceuticals Inc. Hydrazid-derivate von 3,4-dihydro-2h-1-benzopyranen

Also Published As

Publication number Publication date
CA2158036C (en) 1999-07-20
ES2147788T3 (es) 2000-10-01
WO1994020099A1 (en) 1994-09-15
EP0688215A1 (de) 1995-12-27
EP0688215B1 (de) 2000-05-31
DE69424777T2 (de) 2000-11-30
US5451603A (en) 1995-09-19
JPH08506347A (ja) 1996-07-09
GR3034186T3 (en) 2000-11-30
DK0688215T3 (da) 2000-09-11
PT688215E (pt) 2000-10-31
US5480903A (en) 1996-01-02
DE69424777D1 (de) 2000-07-06
CA2158036A1 (en) 1994-09-15

Similar Documents

Publication Publication Date Title
ATE193442T1 (de) 3,4-diarylchromane zur behandlung von dermatitis
NO953542D0 (no) Fremgangsmåte for inhibering av bentap med 3,4-diarylkroman
TR199801180T2 (xx) Aneljestik etkiye sahip yeni bile�ikler.
GEP20002298B (en) Benzimidazole Derivatives, Method of Their Production, Pharmaceutical Composition Containing the Same and Method for Its Treatment
DE3876877D1 (de) Verwendung von indolon-derivaten zur herstellung von arzneimitteln zur behandlung des parkinsonismus.
MY132705A (en) Novel compounds with analgesic effect
BG106095A (en) Novel medicament compositions, based on anticholinergically effective compounds and beta-mimetics
GEP20043269B (en) Purine Derivatives, Method for Their Production and Composition Containing the Same
DK0682514T3 (da) Anvendelse af lokalanæstetiske midler til fremstilling af et lægmiddel til behandling af bronchial astma
ATE205086T1 (de) Verwendung von dem chelatbildner clioquinol zur herstellung eines arzneimittelszur behandlung von alzheimerschen krankheit
YU49026B (sh) UPOTREBA 17 Гџ -(N-TERC-BUTILKARBAMOIL)-4-AZA-5-ALFA-ANDROST-1-3-ON ZA PROIZVODNJU LEKA ZA TRETIRANJE ANDROGENE ALOPECIJE
MX9400630A (es) 6-cloro-5-fluoro-3-(2-tenoil)-2-oxindol-1-carboxamida como un agente analgesico y antiinflamatorio.
ATE235901T1 (de) Pharmazeutische zusammensetzung enthaltend 3-(2,2,2-trimethylhydrazinium)proprionat und gamma- butyrobetain für die behandlung von herz-gefäss- erkrankungen
AU1458495A (en) Application of riluzole in the treatment of mitochondrial diseases
TR199801184T2 (xx) Analjezik tesirli yeni bile�ikler.
AU1604592A (en) New 2-amino-5-cyano-1,4-dihydropyridines, processes for their preparation and their use in medicaments
DE69434002D1 (de) 2,3 diaryl-1-benzopyrame zur behandlung von dermatitis
MY114716A (en) Prophylactic and/or therapeutic treatment of dyspeptic symptoms
ATE91890T1 (de) Herstellung eines arzneimittels gegen arthritis und rheumatismus.
AU1494395A (en) The use of deoxyspergualin for preparing a pharmaceutical for treating hyperreactive inflammatory diseases
UA38388A (uk) Спосіб лікування епідемічного паротиту
RU94023697A (ru) Средство для лечения инфекционного токсикоза у детей раннего возраста
UA10754A (uk) Спосіб лікуваhhя артеріальhих гіпертеhзій різhого геhезу

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee